Skip to main content
Published locations for Phase 2 validates the safety and efficacy of nivolumab with or without ipilimumab in resectable HCC
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Phase 2 validates the safety and efficacy of nivolumab with or without ipilimumab in resectable HCC
User login
Username
Password
Reset your password
/content/phase-2-validates-safety-and-efficacy-nivolumab-or-without-ipilimumab-resectable-hcc-0
/gihepnews/article/252044/hepatocellular-carcinoma/phase-2-validates-safety-and-efficacy-nivolumab-or